•
GN
GNLX
Genelux Corporation Common Stock
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
126.55M
Volume
217.09K
52W High
$8.54
52W Low
$1.99
Open
$2.86
Prev Close
$2.83
Day Range
2.82 - 3.07
About Genelux Corporation Common Stock
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
Latest News
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
GlobeNewswire Inc.•Jan 12
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
GlobeNewswire Inc.•Jan 2
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
GlobeNewswire Inc.•Sep 3
Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024
GlobeNewswire Inc.•Jul 30
Unveiling 4 Analyst Insights On Genelux
Benzinga•May 31
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
GlobeNewswire Inc.•May 24
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
GlobeNewswire Inc.•May 23
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
GlobeNewswire Inc.•May 9